2 Supercharged Dividend Stocks to Buy Now
Biotech stocks have performed well this year. The SPDR S Biotech ETF -- an industry benchmark -- is up 21% this year. Two giants of the industry that have helped drive that performance are (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). These well-known drugmakers have seen positive developments recently, leading to superior returns.
And the best news is that they still have plenty to offer investors, especially those looking for solid income stocks. Here is why Amgen and Gilead Sciences are great dividend stocks to buy.
Image source: Getty Images.
Source Fool.com
Amgen Inc. Aktie
278,05 €
-0,09 %
Die Community bevorzugt Amgen Inc., mit deutlich mehr Buy- (26) als Sell-Einschätzungen (4).
Das von der Community festgelegte Kursziel von 296 € für Amgen Inc. deutet auf ein leichtes Wachstumspotenzial im Vergleich zu 278.05 € hin.
